Novo Nordisk A/S
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Public
- Established
- 1923-01-01
- Employees
- 63.3K
- Market Cap
- $602.2B
- Website
- http://www.novonordisk.com
A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Korea
Completed
- Conditions
- Diabetes Mellitus, Type 2DiabetesDiabetes Mellitus, Type 1
- Interventions
- Other: No treatment given
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 1932
- Registration Number
- NCT00918151
Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery
Phase 2
Completed
- Conditions
- Cardiac Surgery Requiring Cardiopulmonary BypassAcquired Bleeding Disorder
- Interventions
- Drug: placeboDrug: catridecacog
- First Posted Date
- 2009-06-05
- Last Posted Date
- 2017-03-07
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 479
- Registration Number
- NCT00914589
- Locations
- 🇬🇧
Novo Nordisk Investigational Site, Southampton, United Kingdom
Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes
Phase 4
Completed
- Conditions
- Diabetes Mellitus, Type 2Diabetes
- Interventions
- First Posted Date
- 2009-05-28
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 457
- Registration Number
- NCT00909480
- Locations
- 🇹🇭
Novo Nordisk Investigational Site, Pathumthani, Thailand
A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese Subjects
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 2Diabetes
- Interventions
- Other: Oral Glucose Tolerance Test (OGTT)Other: Euglycaemic hyperinsulinaemic clamp
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 271
- Registration Number
- NCT00897169
- Locations
- 🇯🇵
Novo Nordisk Investigational Site, Tokyo, Japan
A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Taiwan
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
- Interventions
- Other: No treatment given
- First Posted Date
- 2009-04-24
- Last Posted Date
- 2016-11-22
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 2370
- Registration Number
- NCT00887874
- Locations
- 🇨🇳
Novo Nordisk Investigational Site, Taipei, Taiwan
PROPACT: Retrospective Prophylaxis Patient Case Collection
Completed
- Conditions
- Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
- Interventions
- First Posted Date
- 2009-04-16
- Last Posted Date
- 2017-01-09
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 86
- Registration Number
- NCT00882778
- Locations
- 🇬🇧
Novo Nordisk Investigational Site, Crawley, United Kingdom
A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Malaysia
Completed
- Conditions
- Diabetes Mellitus, Type 1DiabetesDiabetes Mellitus, Type 2
- Interventions
- Other: No treatment given
- First Posted Date
- 2009-04-07
- Last Posted Date
- 2016-11-22
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 1670
- Registration Number
- NCT00877526
- Locations
- 🇲🇾
Novo Nordisk Investigational Site, Selangor Darul Ehsan, Malaysia
A Survey to Evaluate Diabetes Management, Control, Complications and Psychosocial Aspects of Diabetic Patients in Philippines
Completed
- Conditions
- Diabetes Mellitus, Type 1DiabetesDiabetes Mellitus, Type 2
- Interventions
- Other: No treatment given
- First Posted Date
- 2009-04-02
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 770
- Registration Number
- NCT00874159
Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 1
- Interventions
- First Posted Date
- 2009-04-01
- Last Posted Date
- 2016-10-14
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 417
- Registration Number
- NCT00873639
- Locations
- 🇷🇴
Novo Nordisk Investigational Site, Bucharest, Romania
Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir
Phase 1
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2009-04-01
- Last Posted Date
- 2017-01-26
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 33
- Registration Number
- NCT00873223
- Locations
- 🇺🇸
Novo Nordisk Investigational Site, Chula Vista, California, United States
© Copyright 2025. All Rights Reserved by MedPath